Biologic Therapies for Giant Cell Arteritis
Robert Harrington,* Shamma Ahmad Al Nokhatha,* Richard Conway Department of Rheumatology, St. James’s Hospital, Dublin, Ireland*These authors contributed equally to this workCorrespondence: Richard ConwayDepartment of Rheumatology, St. James’s Hospital, James Street, Dublin 8, Ir...
Guardado en:
Autores principales: | Harrington R, Al Nokhatha SA, Conway R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22c6799b78d44b8195de3ff95920067f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)
por: Alfred Mahr, et al.
Publicado: (2021) -
Isquemia de extremidades inferiores secundaria a arteritis de la arteria temporal
por: Zárate B.,Cristian, et al.
Publicado: (2020) -
Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements
por: Dammacco R, et al.
Publicado: (2020) -
A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
por: Hoon E, et al.
Publicado: (2019) -
Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment
por: Idil Esen, et al.
Publicado: (2021)